According to Neuphoria Therapeutics's latest financial reports the company's current revenue (TTM ) is S$20.32 Million. In 2024 the company made a revenue of S$0.9 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.